147 related articles for article (PubMed ID: 12868125)
21. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
22. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
23. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
[TBL] [Abstract][Full Text] [Related]
25. Bone status in children and adolescents with growth hormone deficiency: effect of growth hormone treatment.
Saggese G; Baroncelli GI
Int J Clin Pract Suppl; 2002 May; (126):18-21. PubMed ID: 12090695
[No Abstract] [Full Text] [Related]
26. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency].
Olsovská V; Siprová H; Beránek M; Soska V
Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102
[TBL] [Abstract][Full Text] [Related]
27. Skeletal consequences of discontinuation of growth hormone at final height.
Drake WM; Carroll PV; Savage MO; Monson JP
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1351-4. PubMed ID: 12510990
[TBL] [Abstract][Full Text] [Related]
28. GH deficiency in the adult and bone.
Doga M; Bonadonna S; Gola M; Mazziotti G; Nuzzo M; Giustina A
J Endocrinol Invest; 2005; 28(8 Suppl):18-23. PubMed ID: 16323825
[TBL] [Abstract][Full Text] [Related]
29. Indications for GH replacement in adolescents and young adults.
Monson JP
J Endocrinol Invest; 2005; 28(5 Suppl):52-5. PubMed ID: 16114277
[TBL] [Abstract][Full Text] [Related]
30. Transition of childhood-onset growth hormone-deficient patients to adult healthcare.
Rapaport R; Cook DM
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():82-90. PubMed ID: 17261975
[TBL] [Abstract][Full Text] [Related]
31. Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques.
Leonard MB
Med Pediatr Oncol; 2003 Sep; 41(3):198-207. PubMed ID: 12868119
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone replacement throughout life: insights into age-related responses to treatment.
Clayton P; Gleeson H; Monson J; Popovic V; Shalet SM; Christiansen JS
Growth Horm IGF Res; 2007 Oct; 17(5):369-82. PubMed ID: 17560153
[TBL] [Abstract][Full Text] [Related]
33. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
Andiran N; Yordam N
Growth Horm IGF Res; 2007 Apr; 17(2):149-53. PubMed ID: 17314057
[TBL] [Abstract][Full Text] [Related]
34. Somatopause: dismetabolic and bone effects.
Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A
J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721
[TBL] [Abstract][Full Text] [Related]
35. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
36. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
37. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency.
Tanriverdi F; Eryol NK; Atmaca H; Unluhizarci K; Ozdogru I; Sarikaya I; Bayram F; Kelestimur F
Clin Endocrinol (Oxf); 2005 Jun; 62(6):706-12. PubMed ID: 15943833
[TBL] [Abstract][Full Text] [Related]
38. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
39. Impaired longitudinal myocardial velocities in patients with growth hormone deficiency improves after hormone replacement therapy.
Ozdogru I; Tanriverdi F; Dogan A; Kaya MG; Tugrul Inanc M; Kalay N; Topsakal R; Unluhizarci K; Atmaca H; Kemal Eryol N; Kelestimur F
J Am Soc Echocardiogr; 2007 Sep; 20(9):1093-9. PubMed ID: 17555934
[TBL] [Abstract][Full Text] [Related]
40. Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults.
Fideleff HL; Boquete H; Giaccio A; Sobrado P;
Medicina (B Aires); 2006; 66(4):296-302. PubMed ID: 16977963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
